Patent · US Active

Liquid pharmaceutical formulations of PTH conjugates

US12403182B2 · kind B2 · utility

0Cited by

17References

8Claims

0Family size

Assignee

ASCENDIS PHARMA BONE DISEASES A/S · DK

Inventors

Anja R. H. Skands · Hellerup, DK
Felix Cleemann · Mainz, DE
Michael Duelund Sørensen · Hellerup, DK
Julia Baron · Heidelberg, DE
Eric Hoffmann · Heidelberg, DE
Kennett Sprogøe · Rudegård, DK

Key dates

Filing date	Feb 10, 2020
Grant date	Sep 2, 2025
Priority date	—
Expiry date	Nov 12, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P5/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A liquid pharmaceutical formulation, wherein the pharmaceutical formulation comprises a PTH conjugate, a buffering agent, an isotonicity agent, a preservative and optionally an antioxidant and wherein the PTH conjugate comprises a PTH moiety that is covalently and reversibly conjugated to a water-soluble carrier moiety.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.